Navigation Links
Human Genome Sciences Advances Oncology Portfolio

ombination with Velcade

(bortezomib) in advanced multiple myeloma, and expects to have data

available in the third quarter of 2008.

-- In December 2007, HGS initiated dosing of approximately 105 patients in

a randomized Phase 2 trial of HGS-ETR1 in combination with paclitaxel

and carboplatin as first-line therapy in advanced non-small cell lung

cancer, and expects to have data available in 2009.

-- Today, HGS announced that it plans by mid-2008 to initiate a randomized

Phase 2 trial of HGS-ETR1 in combination with Nexavar (sorafenib) in

hepatocellular cancer. The study in hepatocellular cancer will begin

with a safety lead-in to assure the safety of this combination therapy

in patients with hepatocellular cancer who are infected with hepatitis


About the HGS IAP Inhibitor Program

In December 2007, the HGS oncology portfolio was further strengthened by a licensing and collaboration agreement between HGS and Aegera Therapeutics Inc. This agreement provides HGS with exclusive worldwide rights (excluding Japan) to develop and commercialize HGS1029 (formerly AEG40826) and other small- molecule inhibitors of IAP (inhibitor of apoptosis) proteins in oncology. Preclinical studies of HGS1029 in combination with the Company's TRAIL receptor antibodies demonstrated dramatic synergistic activity against a number of cancer types. HGS1029 has also shown significant anti-tumor activity alone and in combination with other agents in a broad range of cancers. HGS expects to initiate a Phase 1 clinical trial of HGS1029 by mid-2008 and plans to develop its TRAIL receptor antibodies and IAP inhibitors in combination with one another and in combination with other therapeutic agents.

About HGS-ETR1 and HGS-ETR2

HGS-ETR1 and HGS-ETR2 are agonistic human monoclonal antibodies that directly induce cancer-cell death by specifically binding to and activating th

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources
Post Your Comments:
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic fibrosis ... conductance regulator (CFTR) gene and results in dysfunction of the lungs and the ... the lungs. This mucus is very difficult to clear, blocks the airways and ...
(Date:10/7/2015)... Texas (PRWEB) , ... October 07, 2015 , ... ... Institute ( ) will present a public educational seminar on the latest ... Saturday, October 10th from 1:00 pm – 3:00 pm at the Hilton Dallas/Southlake ...
(Date:10/7/2015)... TRIANGLE PARK, N.C. , Oct. 7, 2015  October ... the campaign, TRL has committed to donating a portion ... current liver research and hepatology practices. ... furthering liver research in a variety of ways; whether ... scientists around the world, collaborating with researchers in different ...
(Date:10/7/2015)... ... October 07, 2015 , ... ... has appointed S. Russel Craig of Spectral Platforms, and Michael Ward of Wrenward ... line management and consulting experience. Currently he is Executive Vice President of Strategic ...
Breaking Biology Technology:
... YORK, July 14, 2011 Coloredge New York - Los ... Graphics Approved Printer Network. A one year alliance, ... Coloredge New York - Los Angeles, was one of 17 ... testing, training and sustainability leadership. Coloredge New York ...
...   Executives from O2h (Cambridge, UK) and ... the number of FTE chemists provided by O2h to support,discovery ... Chemistry at Heptares said, "O2h has,been a valuable partner for ... team to include a full lab unit at,O2h." ...
... soil to release the potent greenhouse gases methane and nitrous ... Nature reveals. "This feedback to our changing atmosphere means ... as we previously thought," said Dr Kees Jan van Groenigen, ... Natural Sciences, Trinity College Dublin, and lead author of the ...
Cached Biology Technology:
(Date:9/29/2015)... -- iDAvatars is excited to be named one of the first ... official announcement was recently made at an invite-only IBM ... San Francisco , where iDAvatars presented a demo of ... "It is both an honor and a privilege to ... market the cognitive power of IBM Watson in our product, ...
(Date:9/28/2015)... , September 28, 2015 The ... to reach USD 12.03 billion by 2020, growing at ... advancements such as Backside Illumination (BSI) technique to improve ... the forecast period.      (Logo: , ... the chip to reduce loss and, thus, reduce the ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of ... will be unveiled today at the Stanford Medicine ... Engagement Using iPad Dashboards, Connected Health Devices and ... of Pharmacy 3.0, will explain how senior patients ... data to their pharmacist via the TactioRPM remote ...
Breaking Biology News(10 mins):
... Northwest (PNW) Research Station has published a report about ... in a changing climate. The report is available online ... print beginning July 9. Titled Water, Climate ... the publication describes healthy, resilient watersheds as a primary ...
... 29 June 2010, announces this year,s award winners with ... theoretical physicist Professor Edward Witten for outstanding, transformative contributions ... physicists of the past 30 years, he has had ... physics and cosmology to theoretical areas of string theory ...
... who drink alcohol while they are pregnant may be damaging ... to be presented at the 26th annual meeting of the ... (Tuesday 29 June). Doctors in Denmark found that if ... pregnant, then the sperm concentration of their sons, measured about ...
Cached Biology News:
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
... to Cholesterol Oxidase Immunogen Cholesterol ... Cross-reacts with bacteria. Not yet tested in ... oxidases exist as both type I and ... bacterial pathogenesis. In addition, they are important ...
Rabbit polyclonal to SERHL ( Abpromise for all tested applications). entrezGeneID: 94009 SwissProtID: Q9H4I8...
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Biology Products: